NCT04312269

Brief Summary

This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2020

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 18, 2020

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

5.9 years

First QC Date

March 9, 2020

Last Update Submit

August 21, 2025

Conditions

Keywords

Sleep

Outcome Measures

Primary Outcomes (1)

  • Wolf Motor Function Test (WMFT)

    The WMFT evaluates upper extremity function on a continuous scale. It measures the time it takes to perform 15 different tasks, with a time limit of 120 s per task.

    change from baseline at 6 weeks

Secondary Outcomes (6)

  • Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function

    change from baseline at 6 weeks

  • Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function

    change from baseline at 10 weeks

  • Motor Activity Log (MAL)

    change from baseline at 6 weeks

  • Motor Activity Log (MAL)

    change from baseline at 10 weeks

  • Modified Ashworth Scale

    change from baseline at 6 weeks

  • +1 more secondary outcomes

Study Arms (4)

All phase TMR

EXPERIMENTAL

TMR during every stage of sleep

Other: Targeted Memory Reactivation (TMR)

Slow-wave sleep (SWS) only TMR

EXPERIMENTAL

TMR during slow-wave sleep only

Other: Targeted Memory Reactivation (TMR)

Reduced frequency TMR

EXPERIMENTAL

TMR during only subset of sessions

Other: Targeted Memory Reactivation (TMR)

Sham TMR

SHAM COMPARATOR

Patients receive no TMR

Other: Targeted Memory Reactivation (TMR)

Interventions

Targeted memory reactivation (TMR) refers to the process of playing audio cues associated with specific learned material quietly during sleep in order to strengthen consolidation of specific memories during sleep.

All phase TMRReduced frequency TMRSham TMRSlow-wave sleep (SWS) only TMR

Eligibility Criteria

Age21 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age at enrollment is 21 or older
  • Hemiparesis from first ever stroke affecting arm movement at least 6 months prior to screening
  • Severe to moderate motor impairment (FMA-UE of 7-40)
  • At least some voluntary shoulder and elbow muscle activation

You may not qualify if:

  • Inability to follow instructions of the MyoCI task
  • Visual impairment (such as hemianopia) preventing full view of screen
  • Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest)
  • Participation in another study on the affected arm within 6 weeks of enrollment or any pharmacological study
  • Inability to understand or follow commands in English due to aphasia or other reason
  • Diffuse or multifocal infarcts in both hemispheres
  • Substantial arm pain preventing participation for 90 minutes a day
  • Spasticity treatment (pharmacological or Botox) within last 3 months
  • Ferromagnetic implants that are MRI incompatible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Marc W Slutzky, MD/PhD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marc W Slutzky, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Outcomes assessors and participant are blinded to groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 9, 2020

First Posted

March 18, 2020

Study Start

February 25, 2020

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Clinical functional outcomes and analyzed EMG (co-activation) will be uploaded and shared upon publication.

Shared Documents
ANALYTIC CODE
Time Frame
IPD and associated analytic code will be made available upon publication of research results and will remain available for the duration of the funded project.

Locations